Sulfonylureas and basal insulin are given if the go-to drug metformin fails Basal insulin makes patients twice as at risk as those taking a newer drug class One in 103 on sulfonylureas will have a cardiovascular event over two years Two commonly–prescribed type 2 diabetes drugs raise a patient’s risk of suffering a heart attack, stroke,...